Brief: Olema Oncology Kat6 Inhibitor Compounds Demonstrate Potent Anti-Tumor Activity
12/10/2023 12:29
Oct 12 (Reuters) - Olema Pharmaceuticals Inc OLMA.O :
* OLEMA ONCOLOGY KAT6 INHIBITOR COMPOUNDS DEMONSTRATE POTENT
ANTI-TUMOR ACTIVITY
Source text for Eikon: ID:nGNX2lN9C
Further company coverage: OLMA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Olema Oncology
See all newsBrief: Olema Pharmaceuticals Changes Corporate Name To Olema Oncology, Effective Today
Olema Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings Summary
Olema Pharma Q3 net loss widens on higher costs
Brief: Olema Pharmaceuticals Q3 Net Income USD -73.599 Million
Olema Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary